227 related articles for article (PubMed ID: 30746785)
1. Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells.
Maimaitiyiming Y; Yang C; Wang Y; Hussain L; Naranmandura H
Biotechnol Appl Biochem; 2019 May; 66(3):412-418. PubMed ID: 30746785
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
Zhang WY; Chen HL; Chen QC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
[TBL] [Abstract][Full Text] [Related]
3. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
[TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation of cell-SELEX enriched aptamers binding to breast cancer cells.
Civit L; Taghdisi SM; Jonczyk A; Haßel SK; Gröber C; Blank M; Stunden HJ; Beyer M; Schultze J; Latz E; Mayer G
Biochimie; 2018 Feb; 145():53-62. PubMed ID: 29054799
[TBL] [Abstract][Full Text] [Related]
5. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
6. Selection and identification of an ssDNA aptamer to NB4 cell.
Zhang XH; Wang W; Chen X
J Clin Lab Anal; 2021 Apr; 35(4):e23718. PubMed ID: 33522630
[TBL] [Abstract][Full Text] [Related]
7. Aptamer Bioinformatics.
Kinghorn AB; Fraser LA; Lang S; Shiu SCC; Tanner JA
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186809
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid aptamers in diagnosis of colorectal cancer.
Ahmadyousefi Y; Malih S; Mirzaee Y; Saidijam M
Biochimie; 2019 Jan; 156():1-11. PubMed ID: 30244135
[TBL] [Abstract][Full Text] [Related]
9. SELEX methods on the road to protein targeting with nucleic acid aptamers.
Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
[TBL] [Abstract][Full Text] [Related]
10. In vitro selection of a DNA aptamer targeted against Shigella dysenteriae.
Duan N; Ding X; Wu S; Xia Y; Ma X; Wang Z; Chen J
J Microbiol Methods; 2013 Sep; 94(3):170-4. PubMed ID: 23811206
[TBL] [Abstract][Full Text] [Related]
11. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for
Zhang L; Zhou L; Zhang H; Zhang Y; Li L; Xie T; Chen Y; Li X; Ling N; Dai J; Sun X; Liu J; Zhao J; Peng T; Ye M
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54656-54664. PubMed ID: 34779207
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
13. Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX.
Haghighi M; Khanahmad H; Palizban A
Molecules; 2018 Mar; 23(4):. PubMed ID: 29561802
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
[TBL] [Abstract][Full Text] [Related]
15. In vitro selection of DNA aptamers against renal cell carcinoma using living cell-SELEX.
Wang J; Zhang Y; Chen Y; Hong S; Sun Y; Sun N; Pei R
Talanta; 2017 Dec; 175():235-242. PubMed ID: 28841985
[TBL] [Abstract][Full Text] [Related]
16. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
17. Cell-SELEX based selection and characterization of DNA aptamer recognizing human hepatocarcinoma.
Ninomiya K; Kaneda K; Kawashima S; Miyachi Y; Ogino C; Shimizu N
Bioorg Med Chem Lett; 2013 Mar; 23(6):1797-802. PubMed ID: 23403083
[TBL] [Abstract][Full Text] [Related]
18. Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis.
Kouhpayeh S; Hejazi Z; Boshtam M; Mirian M; Rahimmanesh I; Darzi L; Rezaei A; Shariati L; Khanahmad H
J Cell Biochem; 2019 Sep; 120(9):16264-16272. PubMed ID: 31111537
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.
Dupont DM; Larsen N; Jensen JK; Andreasen PA; Kjems J
Nucleic Acids Res; 2015 Dec; 43(21):e139. PubMed ID: 26163061
[TBL] [Abstract][Full Text] [Related]
20. Generation of HBsAg DNA aptamer using modified cell-based SELEX strategy.
Mirian M; Kouhpayeh S; Shariati L; Boshtam M; Rahimmanesh I; Darzi L; Taghizadeh R; Jahanian-Najafabadi A; Khanahmad H
Mol Biol Rep; 2021 Jan; 48(1):139-146. PubMed ID: 33400073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
